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Twenty-three patients with symptomatic giant he-
mangioma of the liver were treated by surgery
between 1979 and 1996 at the department of General
Surgery, Faculty of Medicine, University of (ukuro-
va. Twenty-three enucleations were performed in 21
patients, left lateral segmentectomy in one patient
and enucleation plus left lobectomy in one patient.
The tumors were enucleated along the interface
between the hemangioma and normal liver tissue.
The diameters of the tumors ranged from 5x5 to
25x15 cm. The mean blood loss for enucleations was
525 ml (range 500-1000 ml). There was no mortality
and no postoperative bleeding. Three patients had
postoperative complications. Enucleation is the best
surgical technique for symptomatic giant hemangio-
ma of the liver. It may be performed with no
mortality, low morbidity and the preservation of
all normal liver parenchyma.
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cavernous hemangioma of mesenchymal origin.
The etiology of hemangioma is still a matter of
speculation. They vary in size from a few
millimeters to many centimeters. Small heman-
giomas of the liver are usually symptomless, but
giant hemangiomas may be symptomatic.
The natural history of hemangiomas and the
indications for surgical or conservative treat-
ment are controversial. Surgical excision is the
only definitive treatment [1]. Enucleation of
symptomatic giant cavernous hemangiomas of
the liver is emerging as an alternative surgical
technique. We report our personal experience
with enucleation of liver hemangiomas over the
last 16 years.
INTRODUCTION
Hemangiomas are probably the most common
of all liver tumors, and the most frequent is
MATERIAL AND METHODS
Between January 1979 and January 1996, 23
patients underwent operations for symptomatic
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giant hemangiomas of more than 5 centimeters
in diameter. We excluded asymptomatic pa-
tients or hemangiomas less than 5 centimeters in
diameters. There were 18 women and five men
aged 30 to 62 years (Mean 46.7). The indications
for surgery were severe right upper quadrant
pain radiating to right shoulder in six patients,
abdominal discomfort, nausea and vomiting in
three patients, painfull mass felt on physical
examination in ten patients, obstructive jaundice
in two patients, and misdiagnosed hepatocel-
lular carcinoma in two patients. Biochemical
evaluation was normal in all but two patients
who had obstructive jaundice. The lesions were
visualised on radionuclide scans in 4 patients, by
ultrasonography combined with computerized
tomography in 19. The follow-up data was
obtained by examining the hospital record and
an attempt was made to contact them by
telephone and letter.
Operative Technique
Upper midline and subcostal incisions were
used. The falciform and triangular ligaments
were divided and the liver was mobilized
completely. The Pringle maneuver with a soft
clamp was used to achieve inflow control. It was
performed to control bleeding from the enuclea-
tion site in the right or left liver in five patients,
for centrally located hemangiomas in three
patients and following resection procedures for
controlling blood loss from the raw surface of
the liver in two patients. The Pringle maneuver
consisted of periods of 20 min. clamping of the
hepatic pedicle followed by 5 min. periods of
restoration of blood flow.
After incising the liver capsule, finger dissec-
tion was performed in the plane between the
capsule of the hemangioma and the surrounding
liver tissue. Enucleation was accomplished step
by step ligating the vessels entering or leaving
the tumor avoiding entry into either the liver
parenchyma or into the tumor itself.
After removal of the tumor, the defect in the
liver was packed with warm gauze swabs and
small bleeding points were controlled by catgut
sutures. When the defect formed a large cavity
in the liver parenchyma and minimal oozing
persisted inside the cavity despite catgut su-
tures, the omentum was mobilized and placed in
the cavity to prevent formation of an infected
hematoma and secondary infection of the cavity.
A vacuum drain was used for small cavities, but
if the cavity was large, a silastic tube drain were
placed adjacent to the cavity. Drains were
removed within two or three days.
RESULTS
The hemangiomas were solitary in 20 patients
and multiple in 3 patients. The tumor was
located in the right lobe in 14 patients, in the
left lobe in 6 patients and in both lobes in 3
patients.
The tumor dimensions were determined by
US and/6r CT, and during operation. Heman-
giomas varied in size from 5x5 to 25x15 cm.
Twenty-three enucleation were performed in 21
patients, left lateral segmentectomy in one
patient and enucleation plus left lobectomy in
one patient. In the two patients in whom
resections were performed, the hemangiomas
were deeply located in the liver parenchyma.
Obstructive jaundice in two patients due to
pressure of the tumor on the common hepatic
duct was demonstrated by ultra sonography and
computerized tomography. After removal of the
tumor, the common bile duct was explored with
operative cholangiography and it was found to
be normal. These patients became non-jaundiced
after operation.
The mean blood loss during enucleations were
525ml (range, from 500 to 1000 ml). There were
no postoperative bleeds and there were no
deaths. Three patients had postoperative com-
plications. One patient developed pneumonia,
one had a wound infection and one had
subphrenic abcess caused by displacement of
silastic tube. The subphrenic abcess was treatedSYMPTOMATIC GIANT CAVERNOUS HEMANGIOMA 301
by percutaneous drainage. The postoperative
biochemical evaluation was normal in all
patients. The follow-up period ranged from 1
to 16 years (mean 7.4 years). Five patients were
unavailable for follow-up. Sixteen of remaining
eighteen patients were well and asymptomatic.
Mild pain persisted in the epigastric area in two
patients.
DISCUSSION
Cavernous hemangiomas of the liver are found
at autopsy in 2 to 7% of the population [2]. They
affect women predominantly and they are most
frequently encountered in the third, fourth, and
fifth decades of life [3]. The surgical manage-
ment of giant cavernous hemangiomas was
described as early as 1942 by Schumacker [4],
and recently there has been renewed interest in
these tumors because of the advent of noninva-
sive imaging techniques [5,6, 7]. Gaint heman-
gioma of the liver have been variously defined
as a lesion greater than 4, 6, or 8 cm. in diameter
[8,9,10]. Giant hemangiomas may become
symptomatic by pressure on adjacent organs or
the liver. The most common symptom is the
pain and mass effect.
Which cavernous hemangioma should be
treated by surgery? The answer must depend
upon balancing the risks of operation against the
natural history of untreated lesions [11]. From
literature and from our experience, surgical
treatment should be performed to relieve the
symptoms of the hemangioma and to treat the
complications of the hemangioma such as
thrombocytopenia, abcess formation, jaundice,
rupture, and pressure symptoms [12,13,14,15].
Operation for asymptomatic lesions cannot be
routinly recommended even if they are large
because the majority of these lesions do not
increase in size [16]. Which operation should be
performed in patients who merit surgery? Most
authors reported that the surgical strategy was
decided on the basis of the size and the location
of the lesions. When deciding on surgical
management, the operative morbidity and mor-
tality must be considered. Most authors report
major hepatic resection for large tumors and
perform segmentectomy or enucleation only for
smaller lesions [17,18,19,20]. Schwartz [21]
concludes that most large tumors are best
resected along anatomical planes i.e. a lobect-
omy or trisegmentectomy wth inflow vascular
occlusion. Resection of laf..0’e lesions may be
attended by significant blood loss, high post-
operative complication a id the lost normal
functioning liver parencby.na [11,19,21]. Since
the hemangioma is a benign tumor, a technique
of removing it that will spare the parenchyma
seems desirable. The enucleation technique
accomplishes this and it can be performed safely
because involutional changes occur in many
lesions resulting in a firm fibrous capsule,
presumably as a consequence of the compres-
sion of the liver tissue caused by the growing
tumor. Microscopically the tumors are made up
of large blood-filled cavernous sinues lined with
endothelium and separated by fibrous septae of
varying thickness. They are usually encapsu-
lated by a rim of fibrous tissue and the border
between hemangioma and normal liver is dis-
tinct. Histologic examination demonstrates this
plane (Fig. 1). In this interface between heman-
gioma and normal liver tissue, the hemangioma
can be effectively enucleated and the vessels
entering or leaving the tumor can be ligated and
divided one by one. Vascular inflow occlusion
may be used intermittently. Enucleation was
first described by Alper et al. in 1988 [22], and
thereafter Baer et al. [23], Petri et al. [24] and Kuo
et al. [25] reported their experiences. In our
institution, we have been using this surgical
technique since 1979. Pichlmayr [26] reported
that the enucleation technique can be performed
safely even with total vascular occlusion when
the hemangioma is very large or at a dangerous
anatomical location adjacent to the inferior vena
cava or a major hepatic vein. Since the enuclea-
tion occurs along the relatively avascular cap-302 H. DEMIRYOREK et al.
We think that symptomatic gaint hemangio-
mas are best treated by enucleation, no matter
what size.
FIGURE 1 The technique of the enucleation was performed
along the interface between and normal liver paranchyma
that is distinguished by a capsule like fibrous septae (arrows)
(H.E. x 100).
sular plane, the amount of normal functioning
parenchyma removed is minimal. So, the dis-
turbance of liver function is usely insignificant.
The residual cavity can be dealt with by
meticulous dissection, good hemostasis com-
bined with or without omentum placement in
the cavity. In our experience with enucleation
technique, there was no excessive blood loss and
no mortality; the complication rate was rather
low (15 %). When the hemangioma is deeply
located and has an infiltrative character into the
liver parenchyma, the best approach for symp-
tomatic giant hemangioma is the formal resec-
tion [27].
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INVITED COMMENTARY
The authors are to be congratulated for a large
series of excised liver haemangiomas without
mortality or serious morbidity. The paper
emphasises that enucleation is not only feasible
but also preferable in most instances.
Elective surgery of hepatic haemangioma is
indicated if the lesion causes distressing symp-
toms, if the diagnosis is uncertain because of
atypical appearance or concomitant malignant
disease, or if it enlarges progressively.
The risk of spontaneous rupture is minimal
and is not considered to justify the risk of
surgical removal [1-5]. Symptoms, predomi-
nantly pain or discomfort, are related to the size
and site of the lesion; they are commonly rather
vague with a few exceptions like bleeding or
infarction within the haemangioma (giving
acute pain) or pressure on bile ducts or adjacent
structures. Before surgery is comtemplated, it is
therefore important to rule out other disorders
that could explain the symptoms, such as
gallbadder stones, peptic ulcer, reflux eosopha-
gitis, irritable bowel syndrome. In the present
series, 16/18 patients (including the ten patients
who had a painful mass at physical examina-
tion) were rendered asymptomatic by surgery,
which is a good outcome as compared to some
other reports [4,6]. Other authors, having a
more restrictive attitude towards surgery, re-
ported that symptoms, mainly pain, disap-
peared completely or became less severe with
time in 21/25 patients receiving no specific
treatment [4].
The authors state that formal liver resection
should be performed when the haemangioma
is deeply located and infiltrates the liver
parenchyma. I think that the enucleation
method is well suited, and the method of
choice, for centrally or deeply located tumours
together with blood inflow occlusion to decom-
press the haemangioma during removal. I do
not know what the authors mean with infil-
trative haemangiomas, but I agree that infiltra-
tive lesions should be removed by a resection
that gives a safe margin because of the risk of a
hypervascular tumour. A confident distinction
between a hypervascular tumour and a hae-
mangioma cannot be made without tissue
diagnosis. Thus, surgery should be performed
if imaging studies cannot rule out malignancy
or the patient has an expanding tumour or
other signs of malignancy.
Reerences
[1] Trastek, V. F., van Heeden, J. A., Sheedy II, P. F. and
Adson, M. A. (1983). Cavernous hemangiomas of the
liver: resect or observe? Am. J. Surg., 145, 49-53.
[2] Schwartz, S. I. and Cowles Husser, W. (1987). Caver-
nous hemangioma of the liver: a single institution report
of 16 resections. Ann. Surg., 205, 456-465.
[3] Mungovan, J. A., Cronan, J. J. and Vacarro, J. (1994).
Hepatic cavernous hemangiomas lack of enlargement
over time. Radiology, 191, 111-113.
[4] Farges, O., Daradkeh, S. and Bismuth, H. (1995).
Cavernous hemangiomas of the liver: Are there any
indications for resection? World. J. Surg., 19, 19-24.
[5] Egea, A. M., Rodriguez, R. D., Centero, M. V. and
Atenza, J. A. (1996). Indications for surgery in the304 H. DEMIRYOREK et al.
treatment of hepatic hemangioma. Hepatogastroentero-
logy, 43, 422-426
[6] Alper, A., Ariogul, O., Emre, A., Uras, A. and Okten, A.
(1988). Treatment of liver hemangiomas by enucleation.
Arch. Surg., 123, 660-661.
Karl-G Tranberg
Department of Surgery
Lund University
Lund, Sweden